… of DCs pulsed with tumor lysates in preclinical breast cancer (BC… Further clinical trials with
DCV pulsed with HER2/neu or … evaluated in the first phase II clinical trial, including stage III-IV …

… -negative tumor escape following adoptive cell therapy. … Moreover, OVA 257–264
peptide-pulsed FL-DCs were more … passed through a 70-μm filter and red blood cells were lysed …

… phase II study is ongoing 114 . In other clinical trials, intratumoural poly(I:C) derivatives in
combination with DC-based cancer … Regarding the use of whole tumour lysates for vaccination, …

… during phase II studies in prostate and breast cancer (NCT01560923; NCT01042535-phase
II… survival response compared to pulsed DCs with tumor lysate or galactosylceramide alone […

… stimulated with whole cell tumor lysate pulsed-DCs showed … , which indicates whole cell
tumor lysate pulsed-DCs have … revealed that T cells stimulated with tumor lysate pulsed-DCs …

… cells per well) in the presence of tumour lysate (tumour cell to … dendritic cells pulsed with
allogeneic tumour cell lysate … with malignant peritoneal mesothelioma: a phase II clinical trial. …

… study, dendritic cells (DCs) were pulsed with whole‑tumor cell lysates or total RNA of CD44+
colon cancer stem cells (… In addition, DCs pulsed with a tumor lysate derived from the mouse …

… of tumor‑associated … study, α‑gal epitopes were synthesized on the CRC cell line SW620
to increase the immunogenicity of TAAs. DCs were pulsed with α‑gal‑expressing tumor lysate …

… A Phase I/II clinical trial evaluated the efficacy of MUC1 peptide pulsed autologous DC …
Additionally, Adoptive immunotherapy with MUC1-DCs and MUC1-lymphocytes plus gemcitabine …

… function, and T-cell activation in the lymphnode. Checkpoint inhibitors … -tumor immune
response induced by dendritic cell (DC) therapy by blocking PD-(L)1 signaling in the tumor and …